Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy

Authors:	Cathy Anne Pinto Tommi Tervonen Kevin Marsh Dimitra Lambrelli Anna Schultze Andrew Tershakovec Johanna Hyacinthe Thibaud Prawitz Tarek A. Hammad

Abstract:

Keywords:	benefit‐risk assessment myocardial infarction pharmacoepidemiology platelet aggregation inhibitors precision medicine real‐world evidence